Tremfya (guselkumab) is a prescription biologic injection used for the treatment of plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn's disease in eligible patients. By targeting interleukin-23 (IL-23), a key protein involved in inflammation, Tremfya helps support long-term symptom control and disease management as prescribed by a healthcare professional.

Tremfya is administered by subcutaneous injection and is designed for convenient dosing schedules after the initial treatment phase. It may help reduce skin plaques, joint discomfort, and inflammation associated with certain chronic immune-mediated conditions.

Tremfya should only be used under the supervision of a qualified healthcare professional. Regular monitoring may be recommended to help ensure safe and effective treatment.